-
Gilead’s Kite files for FDA approval of second CAR-T — Merck’s Keytruda gets win for triple-negative breast cancer — The House votes on the Lower Drug Cost Now Act — See more on our front page newsDismiss Notice
TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE -
Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.Dismiss Notice
Core Essence
Discussion in 'Arthrex' started by Anonymous, Apr 13, 2010 at 9:39 AM.
Page 1 of 2
Page 1 of 2